Table 3.
Dose (mg zoledronate/mL) | Gap (%) | Surface (%) | ||
---|---|---|---|---|
New bone | Allograft | New bone | Allograft | |
Control (0 mg/mL) | 12 (8–14) | 19 (16–21) | 3 (1–12) | 1 (0–1) |
Low dose (0.005 mg/mL) | 20 (19–23) | 35 (31–39) | 2 (0–2) | 1 (0–1) |
Middle dose (0.05 mg/mL) | 11 (8–14) | 44 (40–46) | 1 (0–3) | 5 (3–7) |
High dose (0.5 mg/mL) | 0 (0–0) | 43 (40–47) | 0 (0–0) | 6 (5–8) |
Values are expressed as medians with interquartile ranges in parentheses.